Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis

2022

O'Shaughnessy J, Woeckel A, Pistilli B, Hegg R, Vahdat LT, Vuina D, Zadeh PA, Smith TW, Kim J, Krop I